These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16172700)

  • 1. A prospective randomized double blind placebo controlled crossover study of fluoxetine efficacy in the prophylaxis of chronic daily headache in children and adolescents.
    Gherpelli JL; Esposito SB
    Arq Neuropsiquiatr; 2005 Sep; 63(3A):559-63. PubMed ID: 16172700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison among clomipramine, fluoxetine, and placebo for the treatment of anxiety disorders in children and adolescents.
    da Costa CZ; de Morais RM; Zanetta DM; Turkiewicz G; Lotufo Neto F; Morikawa M; Rodrigues CL; Labbadia EM; Asbahr FR
    J Child Adolesc Psychopharmacol; 2013 Dec; 23(10):687-92. PubMed ID: 24350814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism.
    Hollander E; Phillips A; Chaplin W; Zagursky K; Novotny S; Wasserman S; Iyengar R
    Neuropsychopharmacology; 2005 Mar; 30(3):582-9. PubMed ID: 15602505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind trial of fluoxetine: chronic daily headache and migraine.
    Saper JR; Silberstein SD; Lake AE; Winters ME
    Headache; 1994 Oct; 34(9):497-502. PubMed ID: 8002320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fluoxetine and placebo in the treatment of obesity.
    Fernández-Soto ML; González-Jiménez A; Barredo-Acedo F; Luna del Castillo JD; Escobar-Jiménez F
    Ann Nutr Metab; 1995; 39(3):159-63. PubMed ID: 7486842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine for migraine prophylaxis: a double-blind trial.
    d'Amato CC; Pizza V; Marmolo T; Giordano E; Alfano V; Nasta A
    Headache; 1999; 39(10):716-9. PubMed ID: 11279947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study.
    Steiner TJ; Ahmed F; Findley LJ; MacGregor EA; Wilkinson M
    Cephalalgia; 1998 Jun; 18(5):283-6. PubMed ID: 9673809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating thermally injured children suffering symptoms of acute stress with imipramine and fluoxetine: a randomized, double-blind study.
    Robert R; Tcheung WJ; Rosenberg L; Rosenberg M; Mitchell C; Villarreal C; Thomas C; Holzer C; Meyer WJ
    Burns; 2008 Nov; 34(7):919-28. PubMed ID: 18675519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study.
    Kara H; Aydin S; Yücel M; Agargün MY; Odabaş O; Yilmaz Y
    J Urol; 1996 Nov; 156(5):1631-2. PubMed ID: 8863556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine for the treatment of fatigue in primary biliary cirrhosis: a randomized, double-blind controlled trial.
    Talwalkar JA; Donlinger JJ; Gossard AA; Keach JC; Jorgensen RA; Petz JC; Lindor KD
    Dig Dis Sci; 2006 Nov; 51(11):1985-91. PubMed ID: 17053955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study.
    Suvanto-Luukkonen E; Koivunen R; Sundström H; Bloigu R; Karjalainen E; Häivä-Mällinen L; Tapanainen JS
    Menopause; 2005; 12(1):18-26. PubMed ID: 15668596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double-blind placebo-controlled study.
    Scahill L; Riddle MA; King RA; Hardin MT; Rasmusson A; Makuch RW; Leckman JF
    J Child Adolesc Psychopharmacol; 1997; 7(2):75-85. PubMed ID: 9334893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial.
    Emslie GJ; Heiligenstein JH; Wagner KD; Hoog SL; Ernest DE; Brown E; Nilsson M; Jacobson JG
    J Am Acad Child Adolesc Psychiatry; 2002 Oct; 41(10):1205-15. PubMed ID: 12364842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
    Mathew NT; Frishberg BM; Gawel M; Dimitrova R; Gibson J; Turkel C;
    Headache; 2005 Apr; 45(4):293-307. PubMed ID: 15836565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents.
    Emslie GJ; Kennard BD; Mayes TL; Nightingale-Teresi J; Carmody T; Hughes CW; Rush AJ; Tao R; Rintelmann JW
    Am J Psychiatry; 2008 Apr; 165(4):459-67. PubMed ID: 18281410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study.
    Emslie GJ; Heiligenstein JH; Hoog SL; Wagner KD; Findling RL; McCracken JT; Nilsson ME; Jacobson JG
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1397-405. PubMed ID: 15502599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
    Robinson RG; Schultz SK; Castillo C; Kopel T; Kosier JT; Newman RM; Curdue K; Petracca G; Starkstein SE
    Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial.
    Geller DA; Hoog SL; Heiligenstein JH; Ricardi RK; Tamura R; Kluszynski S; Jacobson JG;
    J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):773-9. PubMed ID: 11437015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.